Identification of genetic determinants responsible for the rapid immunosuppressive activity and the low leukemogenic potential of a variant of Friend leukemia virus, FIS-2

Journal of Virology

Volumn 72, Issue 2, 1998, Pages 1244-1251

  Dai, Hong Yan ^a   Troseth, Gunn Irene ^a   Gunleksrud, Merete ^a   Bruland, Torunn ^a   Solberg, Liss Anne ^a   Aarset, Harald ^b   Kristiansen, Lena Irene ^a   Dalen, Are ^b  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN; TRANSCRIPTION FACTOR; VIRUS ENVELOPE PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ERYTHROLEUKEMIA CELL; FRIEND LEUKEMIA; FRIEND LEUKEMIA VIRUS; LEUKEMOGENESIS; LONG TERMINAL REPEAT; MOUSE; MURINE LEUKEMIA VIRUS; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; VIRUS GENE; VIRUS PATHOGENESIS; VIRUS TRANSCRIPTION;

EID: 2642618603     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.2.1244-1251.1998     Document Type: Article

References (33)

1. Bendinelli, M., D. Matteucci, and H. Friedman. 1985. Retrovirus induced acquired immunodeficiencies. Adv. Cancer Res. 45:125-181.
2. Borg, K. L., S. A. Nordbc, P. Winge, and A. Dalen. 1995. Detection of cytomegalovirus using 'boosted' nested PCR. Mol. Cell. Probes 9:251-257.
3. Bosze, Z., H. Thiesen, and P. Charnay. 1986. A transcriptional enhancer with specificity for erythroid cells is located in the long terminal repeat of the Friend murine leukemia virus. EMBO J. 5:1615-1623.
4. Celander, D., and W. A. Haseltine. 1984. Tissue-specific transcription preference as a determinant of cell tropism and leukemogenic potential of murine retrovirus. Nature 312:159-163.
5. Chesebro, B., K. Weherly, M. Cloyd, W. Britt, J. Portis, J. Collins, and J. Nishio. 1981. Characterization of mouse monoclonal antibodies specific for Friend murine leukemia virus-induced erythroleukemia cells: Friend-specific and FMR-specific antigens. Virology 112:131-144.
6. Choi, S.-Y., and D. V. Faller. 1994. The long terminal repeats of a murine retrovirus encode a trans-activator for cellular genes. J. Biol. Chem. 269:19691-19694.
7. Choi, S.-Y., and D. V. Faller. 1995. A transcript from the long terminal repeats of a murine retrovirus associated with trans activation of cellular genes. J. Virol. 69:7054-7060.
8. Cunningham, A. J., and A. Szenberg. 1968. Further improvements in the plaque technique for detecting single antibody-forming cells. Immunology 14:599-600.
9. Dai, H. Y., A. Faxvaag, G. I. Troseth, H. Aarset, and A. Dalen. 1994. Molecular cloning and characterization of an immunosuppressive and weakly oncogenic variant of Friend murine leukemia virus, FIS-2. J. Virol. 68:6976-6984.
10. Dai, H. Y., and L. A. Solberg. Unpublished data.
11. Doig, D., and B. Chesebro. 1979. Anti-Friend virus antibody is associated with recovery from viremia and loss of viral leukemia cell-surface antigens in leukemic mice. Identification of Rfv-3 as a gene locus influencing antibody production. J. Exp. Med. 150:10-19.
12. Faller, D. V., H. Weng, D. T. Graves, and S.-Y. Choi. 1997. Moloney murine leukemia virus long terminal repeat activates monocyte chemotactic protein-1 protein expression and chemotactic activity. J. Cell. Physiol. 172:240-252.
13. Farrar, J. J., J. Fuller-Farrar, P. L. Simon, M. L. Hilfiker, B. M. Stadler, and W. L. Farrar. 1980. Thymoma production of T cell growth factor (interleukin 2). J. Immunol. 125:2555-2558.
14. Gorman, C. M., L. F. Moffat, and B. H. Howard. 1982. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol. Cell. Biol. 2:1044-1051.
15. Graham, F. L., and A. J. van der Eb. 1973. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52:456-467.
16. Haraguchi, S., R. A. Good, and N. K. Day. 1995. Immunosuppressive retroviral peptides: cAMP and cytokine patterns. Immunol. Today 16:595-603.
17. Hasenkrug, K. J., and B. Chesebro. 1997. Immunity to retroviral infection: the Friend virus model. Proc. Natl. Acad. Sci. USA 94:7811-7816.
18. Holt, C. A., K. Osorio, and F. Lilly. 1986. Friend virus-specific cytotoxic T lymphocytes recognize both gag and env gene-encoded specificities. J. Exp. Med. 164:211-226.
19. Koren, H. S., B. S. Handwerger, and J. R. Wunderlich. 1975. Identification of macrophage-like characteristics in a cultured murine tumor line. J. Immunol. 114:894-897.
20. Lanier, L. L., M. Lynes, G. Haughton, and P. J. Wettstein. 1978. Novel type of murine B-cell lymphoma. Nature 271:554-555.
21. Li, Y., E. Golemis, J. W. Hartley, and N. Hopkins. 1987. Disease specificity of nondefective Friend and Moloney murine leukemia viruses is controlled by a small number of nucleotides. J. Virol. 61:693-700.
22. McGrath, M. S., E. Pillemer, D. Kooistra, and I. L. Weissmann. 1980. The role of MuLV receptors on T-lymphoma cells in lymphoma cell proliferation. p. 157-184. In N. L. Warner (ed.), Contemporary topics in immunology. Plenum Publishing Corp., New York, N.Y.
23. Morrison, R. P., J. Nishio, and B. Chesebro. 1986. Influence of the murine MHC (H-2) on Friend leukemia virus-induced immunosuppression. J. Exp. Med. 163:301-314.
24. Oshima, M., T. Odawara, T. Matano, H. Sakahira, Y. Kuchino, A. Iwamoto, and H. Yoshikura. 1996. Possible role of splice acceptor site in expression of unspliced gag-containing message of Moloney murine leukemia virus. J. Virol. 70:2286-2295.
25. Robert-Guroff, M., M. Brown, and R. C. Gallo. 1985. HTLV-III-neutralizing antibodies in patients with AIDS and AIDS-related complex. Nature 316:72-74.
26. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
27. Short, M. K., S. A. Okenquist, and J. Lenz. 1987. Correlation of leukemogenic potential of murine retroviruses with transcriptional tissue preference of the viral long terminal repeats. J. Virol. 61:1067-1072.
28. Sitbon, M., L. D'Auriol, H. Ellerbrok, C. Andre, J. Nishio, S. Perryman, F. Pozo, S. F. Hayes, K. Weherly, P. Tambourin, F. Galibert, and B. Chesebro. 1991. Substitution of leucine for isoleucine in a sequence highly conserved among retroviral envelope surface glycoproteins attenuates the lytic effect of the Friend murine leukemia virus. Proc. Natl. Acad. Sci. USA 88:5932-5936.
29. Snyderman, R., and G. J. Cianciolo. 1984. Immunosuppressive activity of the retroviral envelope protein p15E and its possible relationship to neoplasia. Immunol. Today 5:240-244.
30. Soldaini, E., D. Matteucci, M. Lopez-Cepero, S. Specter, H. Friedman, and M. Bendinelli. 1989. Friend leukemia complex infection of mice as an experimental model for AIDS studies. Vet. Immunol. Immunopathol. 21:97-110.
31. Troxler, D. H., S. K. Ruscetti, and E. M. Scolnick. 1980. The molecular biology of Friend virus. Biochim. Biophys. Acta 605:305-324.
32. Weiss, R. A., P. R. Clapham, R. Cheingsong-Popov, A. G. Dalgleish, C. A. Carne, I. V. D. Weller, and R. S. Tedder. 1985. Neutralization of human T-lymphotropic virus type III by sera of AIDS and AIDS-risk patients. Nature 316:69-72.
33. Wilkinson, D. G. 1992. In situ hybridization. A practical approach. IRL Press, Oxford, England.